A Study Evaluating the Efficacy of Obinutuzumab and Bendamustine Treatment in Participants With Refractory or Relapsed Chronic Lymphocytic Leukemia
Clinical trial NCT02071225 · COMPLETED
Trial details
- NCT number
- NCT02071225
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-09
- Primary completion
- 2018-11-19
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.